{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:15Z","timestamp":1792788495899,"version":"4.5.0"},"reference-count":31,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Resection of brain metastases (BMs) may be associated with increased risk of leptomeningeal disease (LMD). This study examined rates and predictors of LMD, including imaging subtypes, in patients who underwent resection of a BM followed by postoperative radiation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>A retrospective, single-center study was conducted examining overall LMD, classic LMD (cLMD), and nodular LMD (nLMD) risk. Logistic regression, Cox proportional hazards, and random forest analyses were performed to identify risk factors associated with LMD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Of the 217 patients in the cohort, 47 (21.7%) developed postoperative LMD, with 19 cases (8.8%) of cLMD and 28 cases (12.9%) of nLMD. Six-, 12-, and 24-month LMD-free survival rates were 92.3%, 85.6%, and 71.4%, respectively. Patients with cLMD had worse survival outcomes from the date of LMD diagnosis compared with nLMD (median 2.4 vs 6.9 months, p = 0.02, log-rank test). Cox proportional hazards analysis identified cerebellar\/insular\/occipital location (hazard ratio [HR] 3.25, 95% confidence interval [CI] 1.73\u20136.11, p = 0.0003), absence of extracranial disease (HR 2.49, 95% CI 1.27\u20134.88, p = 0.008), and ventricle contact (HR 2.82, 95% CI 1.5\u20135.3, p = 0.001) to be associated with postoperative LMD. A predictive model using random forest analysis with an area under the receiver operating characteristic curve of 0.87 in a test cohort identified tumor location, systemic disease status, and tumor volume as the most important factors associated with LMD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>Tumor location, absence of extracranial disease at the time of surgery, ventricle contact, and increased tumor volume were associated with LMD. Further work is needed to determine whether escalating therapies in patients at risk of LMD prevents disease dissemination.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2022.12.jns221490","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T12:46:57Z","timestamp":1673614017000},"page":"402-413","source":"Crossref","is-referenced-by-count":18,"title":["Identification of risk factors associated with leptomeningeal disease after resection of brain metastases"],"prefix":"10.3171","volume":"139","author":[{"given":"Ramin A.","family":"Morshed","sequence":"first","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satvir","family":"Saggi","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Cummins","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette M.","family":"Molinaro","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob S.","family":"Young","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Viner","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier E.","family":"Villanueva-Meyer","sequence":"additional","affiliation":[{"name":"Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"Goldschmidt","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Boreta","sequence":"additional","affiliation":[{"name":"Radiation Oncology, University of California, San Francisco, California and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E.","family":"Braunstein","sequence":"additional","affiliation":[{"name":"Radiation Oncology, University of California, San Francisco, California and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"Chang","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"McDermott","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Miami Neuroscience Institute, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchel S.","family":"Berger","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip V.","family":"Theodosopoulos","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn L.","family":"Hervey-Jumper","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish K.","family":"Aghi","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariza","family":"Daras","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"1","key":"b1","series-title":"Curr Oncol Rep","first-page":"48","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak L","year":"2012","unstructured":"Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep. 2012;14(1):48\u201354.22012633"},{"issue":"8","key":"b2","series-title":"N Engl J Med","first-page":"722","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi HA","year":"2018","unstructured":"Tawbi HA, Forsyth PA, Algazi A,  Combined nivolumab and ipilimumab in melanoma metastatic to the brain. N Engl J Med. 2018;379(8):722\u2013730."},{"issue":"7","key":"b3","series-title":"Lancet Oncol","first-page":"976","article-title":"Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial","volume":"17","author":"Goldberg SB","year":"2016","unstructured":"Goldberg SB, Gettinger SN, Mahajan A,  Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. Lancet Oncol. 2016;17(7):976\u2013983.27267608"},{"issue":"1","key":"b4","series-title":"J Immunother Cancer","first-page":"e000333","article-title":"Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG study in 380 patients","volume":"8","author":"Amaral T","year":"2020","unstructured":"Amaral T, Kiecker F, Schaefer S,  Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG study in 380 patients. J Immunother Cancer. 2020;8(1):e000333.32221017"},{"issue":"12","key":"b5","series-title":"Lancet Oncol","first-page":"1692","article-title":"Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study","volume":"22","author":"Tawbi HA","year":"2021","unstructured":"Tawbi HA, Forsyth PA, Hodi FS,  Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study. Lancet Oncol. 2021;22(12):1692\u20131704.34774225"},{"issue":"33","key":"b6","series-title":"J Clin Oncol","first-page":"3282","article-title":"Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504): a phase III, noninferiority, randomized controlled trial","volume":"36","author":"Kayama T","year":"2018","unstructured":"Kayama T, Sato S, Sakurada K,  Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504): a phase III, noninferiority, randomized controlled trial. J Clin Oncol. 2018;36(33):3282\u20133289."},{"issue":"2","key":"b7","series-title":"J Clin Oncol","first-page":"134","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study","volume":"29","author":"Kocher M","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U,  Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011;29(2):134\u2013141."},{"issue":"8","key":"b8","series-title":"Lancet Oncol","first-page":"1040","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan A","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF,  Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18(8):1040\u20131048.28687375"},{"issue":"8","key":"b9","series-title":"Lancet Oncol","first-page":"1049","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown PD","year":"2017","unstructured":"Brown PD, Ballman KV, Cerhan JH,  Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18(8):1049\u20131060.28687377"},{"issue":"1","key":"b10","series-title":"J Neurooncol","first-page":"163","article-title":"Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery","volume":"120","author":"Huang AJ","year":"2014","unstructured":"Huang AJ, Huang KE, Page BR,  Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery. J Neurooncol. 2014;120(1):163\u2013169.25048529"},{"issue":"3","key":"b11","series-title":"Int J Radiat Oncol Biol Phys","first-page":"537","article-title":"Surgical resection of brain metastases and the risk of leptomeningeal recurrence in patients treated with stereotactic radiosurgery","volume":"94","author":"Johnson MD","year":"2016","unstructured":"Johnson MD, Avkshtol V, Baschnagel AM,  Surgical resection of brain metastases and the risk of leptomeningeal recurrence in patients treated with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2016;94(3):537\u2013543.26867883"},{"issue":"suppl","key":"b12","series-title":"J Neurosurg","first-page":"75","article-title":"Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis","volume":"121","author":"Ojerholm E","year":"2014","unstructured":"Ojerholm E, Lee JYK, Thawani JP,  Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis. J Neurosurg. 2014;121(suppl):75\u201383."},{"key":"b13","series-title":"J Clin Neurosci","first-page":"48","article-title":"Postoperative radiosurgery for the treatment of metastatic brain tumor: Evaluation of local failure and leptomeningeal disease","volume":"49","author":"Foreman PM","year":"2018","unstructured":"Foreman PM, Jackson BE, Singh KP,  Postoperative radiosurgery for the treatment of metastatic brain tumor: Evaluation of local failure and leptomeningeal disease. J Clin Neurosci. 2018;49:48\u201355.29248376"},{"issue":"2","key":"b14","series-title":"Neurosurgery","first-page":"279","article-title":"Comparing preoperative with postoperative stereotactic radiosurgery for resectable brain metastases: a multi-institutional analysis","volume":"79","author":"Patel KR","year":"2016","unstructured":"Patel KR, Burri SH, Asher AL,  Comparing preoperative with postoperative stereotactic radiosurgery for resectable brain metastases: a multi-institutional analysis. Neurosurgery. 2016;79(2):279\u2013285.26528673"},{"issue":"4","key":"b15","series-title":"Neurosurgery","first-page":"664","article-title":"Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis","volume":"64","author":"Suki D","year":"2009","unstructured":"Suki D, Hatiboglu MA, Patel AJ,  Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis. Neurosurgery. 2009;64(4):664\u2013676."},{"issue":"5","key":"b16","series-title":"Neurosurgery","first-page":"632","article-title":"Hemorrhagic and cystic brain metastases are associated with an increased risk of leptomeningeal dissemination after surgical resection and adjuvant stereotactic radiosurgery","volume":"85","author":"Press RH","year":"2019","unstructured":"Press RH, Zhang C, Chowdhary M,  Hemorrhagic and cystic brain metastases are associated with an increased risk of leptomeningeal dissemination after surgical resection and adjuvant stereotactic radiosurgery. Neurosurgery. 2019;85(5):632\u2013641.30335175"},{"issue":"4","key":"b17","series-title":"Int J Radiat Oncol Biol Phys","first-page":"713","article-title":"Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases","volume":"87","author":"Atalar B","year":"2013","unstructured":"Atalar B, Modlin LA, Choi CYH,  Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys. 2013;87(4):713\u2013718.24054875"},{"issue":"8","key":"b18","series-title":"Neuro Oncol","first-page":"1049","article-title":"A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases","volume":"21","author":"Prabhu RS","year":"2019","unstructured":"Prabhu RS, Turner BE, Asher AL,  A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases. Neuro Oncol. 2019;21(8):1049\u20131059.30828727"},{"issue":"5","key":"b19","series-title":"JAMA Oncol","first-page":"703","article-title":"Association of neurosurgical resection with development of pachymeningeal seeding in patients with brain metastases","volume":"5","author":"Cagney DN","year":"2019","unstructured":"Cagney DN, Lamba N, Sinha S,  Association of neurosurgical resection with development of pachymeningeal seeding in patients with brain metastases. JAMA Oncol. 2019;5(5):703\u2013709.30844036"},{"issue":"3","key":"b20","series-title":"Int J Radiat Oncol Biol Phys","first-page":"579","article-title":"Nodular leptomeningeal disease-a distinct pattern of recurrence after postresection stereotactic radiosurgery for brain metastases: a multi-institutional study of interobserver reliability","volume":"106","author":"Turner BE","year":"2020","unstructured":"Turner BE, Prabhu RS, Burri SH,  Nodular leptomeningeal disease-a distinct pattern of recurrence after postresection stereotactic radiosurgery for brain metastases: a multi-institutional study of interobserver reliability. Int J Radiat Oncol Biol Phys. 2020;106(3):579\u2013586.31605786"},{"key":"b21","series-title":"Monte Carlo Calibration of Distributions of Partition Statistics","author":"Sall J","year":"2002","unstructured":"Sall J. Monte Carlo Calibration of Distributions of Partition Statistics. SAS; 2002.Accessed December 13, 2022.https:\/\/www.jmp.com\/content\/dam\/jmp\/documents\/en\/white-papers\/montecarlocal.pdf"},{"issue":"1","key":"b22","series-title":"J Neurosurg","first-page":"86","article-title":"Supervised machine learning algorithms demonstrate proliferation index correlates with long-term recurrence after complete resection of WHO grade I meningioma","volume":"138","author":"Nguyen MP","year":"2023","unstructured":"Nguyen MP, Morshed RA, Dalle Ore CL,  Supervised machine learning algorithms demonstrate proliferation index correlates with long-term recurrence after complete resection of WHO grade I meningioma. J Neurosurg. 2023;138(1):86\u201394."},{"issue":"1","key":"b23","series-title":"Mach Learn","first-page":"5","article-title":"Random forests","volume":"45","author":"Breiman L","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45(1):5\u201332."},{"issue":"5","key":"b24","series-title":"Lancet Neurol","first-page":"443","article-title":"Neoplastic meningitis","volume":"5","author":"Gleissner B","year":"2006","unstructured":"Gleissner B, Chamberlain MC. Neoplastic meningitis. Lancet Neurol. 2006;5(5):443\u2013452.16632315"},{"issue":"1","key":"b25","series-title":"Cancer","first-page":"21","article-title":"Leptomeningeal metastasis from systemic cancer: Review and update on management","volume":"124","author":"Wang N","year":"2018","unstructured":"Wang N, Bertalan MS, Brastianos PK. Leptomeningeal metastasis from systemic cancer: Review and update on management. Cancer. 2018;124(1):21\u201335.29165794"},{"issue":"2","key":"b26","series-title":"J Neurooncol","first-page":"395","article-title":"Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery","volume":"136","author":"Ma R","year":"2018","unstructured":"Ma R, Levy M, Gui B,  Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery. J Neurooncol. 2018;136(2):395\u2013401.29159778"},{"issue":"1","key":"b27","series-title":"Radiat Oncol","first-page":"106","article-title":"Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis","volume":"12","author":"Lamba N","year":"2017","unstructured":"Lamba N, Muskens IS, DiRisio AC,  Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis. Radiat Oncol. 2017;12(1):106.28646895"},{"issue":"2","key":"b28","series-title":"Surg Neurol","first-page":"181","article-title":"Boost radiosurgery for treatment of brain metastases after surgical resections","volume":"69","author":"Iwai Y","year":"2008","unstructured":"Iwai Y, Yamanaka K, Yasui T. Boost radiosurgery for treatment of brain metastases after surgical resections. Surg Neurol. 2008;69(2):181\u2013186.18261647"},{"issue":"1","key":"b29","series-title":"Neurooncol Adv","first-page":"vdab162","article-title":"Leptomeningeal disease in neurosurgical brain metastases patients: a systematic review and meta-analysis","volume":"3","author":"Tewarie IA","year":"2021","unstructured":"Tewarie IA, Jessurun CAC, Hulsbergen AFC, Smith TR, Mekary RA, Broekman MLD. Leptomeningeal disease in neurosurgical brain metastases patients: a systematic review and meta-analysis. Neurooncol Adv. 2021;3(1):vdab162.34859226"},{"issue":"12","key":"b30","series-title":"J Immunother Cancer","first-page":"e003730","article-title":"Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases","volume":"9","author":"Minniti G","year":"2021","unstructured":"Minniti G, Lanzetta G, Capone L,  Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases. J Immunother Cancer. 2021;9(12):e003730."},{"issue":"3","key":"b31","series-title":"Int J Radiat Oncol Biol Phys","first-page":"764","article-title":"Preoperative radiosurgery for resected brain metastases: the PROPS-BM multicenter cohort study","volume":"111","author":"Prabhu RS","year":"2021","unstructured":"Prabhu RS, Dhakal R, Vaslow ZK,  Preoperative radiosurgery for resected brain metastases: the PROPS-BM multicenter cohort study. Int J Radiat Oncol Biol Phys. 2021;111(3):764\u2013772.34058254"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/139\/2\/article-p402.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/139\/2\/article-p402.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/139\/2\/article-p402.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T10:45:53Z","timestamp":1716029153000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/139\/2\/article-p402.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":31,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2022.12.jns221490","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}